MENU
+Compare
AORT
Stock ticker: NYSE
AS OF
Oct 15, 11:16 AM (EDT)
Price
$41.63
Change
+$0.61 (+1.49%)
Capitalization
1.94B

AORT Artivion Forecast, Technical & Fundamental Analysis

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions... Show more

AORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AORT with price predictions
Oct 14, 2025

AORT's Indicator enters downward trend

The Aroon Indicator for AORT entered a downward trend on October 10, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 151 similar instances where the Aroon Indicator formed such a pattern. In of the 151 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 66 cases where AORT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on October 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AORT as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

AORT moved below its 50-day moving average on October 09, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AORT crossed bearishly below the 50-day moving average on October 10, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AORT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AORT advanced for three days, in of 289 cases, the price rose further within the following month. The odds of a continued upward trend are .

AORT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AORT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.608) is normal, around the industry mean (61.244). P/E Ratio (0.000) is within average values for comparable stocks, (37.499). AORT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.685). AORT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (4.327) is also within normal values, averaging (79.870).

View a ticker or compare two or three
AORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AORT is expected to report earnings to fall 89.29% to 2 cents per share on October 30

Artivion AORT Stock Earnings Reports
Q3'25
Est.
$0.03
Q2'25
Beat
by $0.24
Q1'25
Beat
by $0.06
Q4'24
Missed
by $0.33
Q3'24
Beat
by $0.18
The last earnings report on August 07 showed earnings per share of 23 cents, beating the estimate of 0 cents. With 36.26K shares outstanding, the current market capitalization sits at 1.94B.
A.I.Advisor
published Dividends

AORT paid dividends on December 18, 2015

Artivion AORT Stock Dividends
А dividend of $0.03 per share was paid with a record date of December 18, 2015, and an ex-dividend date of December 09, 2015. Read more...
A.I. Advisor
published General Information

General Information

a provider of cryopreserved human tissue for vascular transplant applications

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1655 Roberts Boulevard North West
Phone
+1 770 419-3355
Employees
1500
Web
https://www.artivion.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OFSFX21.62N/A
N/A
Olstein Strategic Opportunities Adviser
REVCX13.39N/A
N/A
Columbia Global Value C
EAASX32.47N/A
N/A
Eaton Vance Atlanta Capital SMID-Cap A
HRVIX35.42N/A
N/A
Heartland Value Plus Investor
MSFBX33.19N/A
N/A
Morgan Stanley Inst Global Franchise A

AORT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AORT has been loosely correlated with VREX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AORT jumps, then VREX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AORT
1D Price
Change %
AORT100%
+0.96%
VREX - AORT
44%
Loosely correlated
+2.04%
TCMD - AORT
43%
Loosely correlated
+2.17%
LMAT - AORT
42%
Loosely correlated
+2.43%
SONVY - AORT
42%
Loosely correlated
-0.46%
ITGR - AORT
41%
Loosely correlated
+1.83%
More

Groups containing AORT

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AORT
1D Price
Change %
AORT100%
+0.96%
Medical/Nursing Services
industry (220 stocks)
45%
Loosely correlated
+0.04%
Health Services
industry (430 stocks)
29%
Poorly correlated
+0.06%